Brief: Angion Announces Phase 1B Trial Of Ang-3070 In Patients With Idiopathic Pulmonary Fibrosis

Elicio Therapeutics

16/05/2022 05:06

May 16 (Reuters) - Angion Biomedica Corp  ANGN.O :
    * ANGION ANNOUNCES PHASE 1B TRIAL OF ANG-3070 IN PATIENTS
WITH
IDIOPATHIC PULMONARY FIBROSIS
    * PHASE 1B STUDY IS INTENDED TO START ENROLLMENT AND REPORT
DATA
IN 2022
    * FDA HAS ACCEPTED AN IND APPLICATION SUPPORTING CLINICAL
DEVELOPMENT OF ANG-3070 IN IPF

Source text for Eikon:  ID:nGNXbCJ5JB 
Further company coverage:  ANGN.O 

 ((Reuters.Briefs@thomsonreuters.com;))